Azora Therapeutics, Inc. (DE)

AZRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$10.635 M

$4.05 -2.41%

Close of 5 Nov 2026

As of 5 Nov 2026, Azora Therapeutics, Inc. (DE) (AZR) has a market capitalization of $10.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$7.98T

Loss-making

Shares outstanding

2,625,890

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Azora Therapeutics, Inc. (DE) lists more than one class of stock. Company figures above cover all classes combined.

ADIL

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#412Rocket OneRKTO$11.0M
#413Palatin TechnologiesPTN$10.7M
#414Azora Therapeutics, Inc. (DE)AZR$10.6M
#415CytoMed TherapeuticsGDTC$10.5M
#416Aspire-LakewoodASBP$10.3M

What if Azora Therapeutics, Inc. (DE) were worth as much as…

Open the what-if tool →

Gold $28.1T

$10,693,773

Per share 2,640,438× higher

Bitcoin $1.53T

$583,003.56

Per share 143,951× higher

Apple $5.08T

$1,934,256

Per share 477,594× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Azora Therapeutics, Inc. (DE) are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.